Cardiovascular Surgery and Interventions 2018, Vol 5, Num 2 Page(s): 027-029
Percutaneous cholecystostomy in acute cholecystitis in a patient with stent restenosis suffering from recent non-ST myocardial infarction before coronary artery bypass grafting

Cüneyt Arkan1, Nuri Havan2, Selçuk Gülmez3, Muharrem Dağlı1, Mehmet Erdem Toker1

1Department of Cardiovascular Surgery, Kartal Koşuyolu Yüksek İhtisas Training and Research Hospital, Istanbul, Turkey
2Department of Radiology, Kartal Koşuyolu Yüksek İhtisas Training and Research Hospital, Istanbul, Turkey
3Department of Gastroenterology Surgery, Kartal Koşuyolu Yüksek İhtisas Training and Research Hospital, Istanbul, Turkey

Keywords: Acute cholecystitis; comorbidities; coronary artery bypass grafting; percutaneous cholecystostomy
It may be challenging to tailor the treatment of acute cholecystitis in patients undergoing coronary artery bypass grafting due to accompanying comorbid factors. A 62-year-old male patient was admitted to the cardiovascular surgery unit for elective coronary artery bypass grafting. He suffered from non-ST-elevation myocardial infarction a week ago. His medical history revealed insulin-dependent diabetes mellitus and severe chronic obstructive pulmonary disease and also percutaneous coronary interventions in the left anterior descending and circumflex arteries 18 month ago. A coronary artery bypass grafting operation was planned a week after his admission. However, before coronary artery bypass grafting, the patient suffered from abdominal pain, nausea, and vomiting and the diagnosis of acute cholecystitis was made by the gastroenterology department. Percutaneous cholecystostomy was applied under ultrasonographic guidance. After the procedure, the complaints of the patient improved dramatically. Twelve days after the procedure, coronary artery bypass grafting was performed without any perioperative complications. The patient was uneventfully discharged on postoperative Day 8. In conclusion, percutaneous cholecystostomy is an effective method to maintain clinical stability in patients with acute cholecystitis who are candidates for open heart surgery.

DOI : 10.5606/e-cvsi.2018.699